Heart-Sparing Radiation for Stage 3 Lung Cancer
Part of Heart & circulation, Injuries & trauma clinical trials.
This study tests a new way of planning radiation therapy for stage 3 lung cancer. By carefully mapping the heart's structure, doctors aim to protect it from radiation and improve treatment safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (NSCLC).
- Your cancer is stage 3, meaning it's locally advanced but hasn't spread far.
- You will receive radiation therapy at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan.
- You have not had radiation therapy to your chest before.
- You have not had heart surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether focusing radiation only on the main tumor (not the surrounding area) is safe and effective for people with stage 3 lung cancer that cannot be removed with surgery. It aims to reduce side effects while keeping the treatment working.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
This study looks at medical images and health records from people treated with radiation for early-stage non-small cell lung cancer to better understand how radiation affects the heart and lungs. This could help doctors prevent side effects in future patients.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
Hear when a new Locally Advanced Lung Non-Small Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.